Evidence-led acquisition screening

Screen the deal before conviction.

Aquerim is an evidence-led acquisition-screening platform for UK SME buyers and advisers. Its AI-assisted workflow turns early-stage deal documents into a screening report: a defensible earnings view, risks, evidence gaps and questions for professional review.

Early-stage decision support. Not financial, legal, investment or full due-diligence advice.

Fictional test dealPublic beta example

One report. A direct test.

The Copper Kettle story, in three lines.

We are not asking you to admire the interface. We want to know whether the analysis would have changed a real screening decision.

The seller’s position

The fictional target was marketed at £295,000 with £119,000 of presented earnings.

The reconstructed view

Aquerim rebuilt the bridge to £26,100 of defensible earnings, implying an 11.3x multiple.

The questions left open

Unsupported add-backs, a public-record mismatch, lease exposure and missing documents became explicit verification points.

What the product is trying to do

Put the report between the sales story and your next cheque.

Rebuild the earnings story

Reported profit, owner pay, seller adjustments and defensible earnings are separated into a visible bridge.

Show what supports each finding

The report distinguishes supplied evidence, analytical inference and matters that remain unverified.

Keep missing data visible

Documents that were not supplied reduce confidence. Their absence is not quietly converted into certainty.

Focus professional review

The output is designed to sharpen the next accounting, legal and commercial questions, not answer them by decree.

Nine stages. One traceable screen.

From deal files to a report you can challenge.

AI assists extraction, comparison and synthesis while the workflow keeps source evidence, analytical judgement and unresolved questions distinct. It narrows uncertainty without pretending to replace the advisers who verify a live acquisition.

Frame the evidence

Deal context

Fix the target, location, asking price and likely structure so every later finding stays attached to the same transaction.

Document intake

Extract the supplied accounts, tax records, leases, contracts and supporting files without treating absence as evidence.

Quality gate

Structure the material, surface contradictions and stop when the evidence is not safe enough to analyse.

Run the analysis

AI-assisted review

AI assists parallel financial, legal and public-record review, constrained to supplied evidence, explicit rules and stated limits.

Market sense-check

Test the valuation basis, implied multiple and commercial position against relevant external context.

Risk scorecard

Bring evidence quality and the analysis together into an explicit view of confidence, exposure and priority.

Challenge the output

Synthesis

Turn the separate findings into strengths, risks, next steps and clearly stated verification gaps.

QA challenge

Test contradictions, completeness and calibration before anything is released to the buyer.

Report render

Produce a traceable screening report that keeps evidence, inference and adviser questions visibly separate.

The result is decision support for the next conversation, not financial, legal, tax, investment, valuation or full due-diligence advice.

A report that leaves its working in

Useful conclusions should remain challengeable.

Inspect the full example
Evidence

What was actually supplied?

Accounts, seller adjustments, lease terms, agreements and public records are treated as separate sources with different evidential weight.

Interpretation

What can reasonably be inferred?

Findings are framed against the documents, with confidence and limitations kept visible beside the analysis.

Verification

What still needs a professional?

Unresolved accounting, tax, legal and commercial questions are directed toward adviser review before any decision is made.

The boundary matters

A sharper screen, not a substitute for judgement.

Aquerim is an early-stage screening tool. It organises supplied evidence, highlights inconsistencies and helps buyers decide what deserves deeper review.

It does not recommend whether to acquire a business and does not replace financial, legal, tax, investment, valuation or full due-diligence advice. Findings should be independently verified by appropriate advisers.